Influence of seasonal variation on severity and outcomes in acute bronchiolitis

Shaik Ateal Saheb; R. Samba Siva Reddy

doi:10.18203/2349-3291.ijcp20174725

Authors

Shaik Ateal Saheb Department of Pediatrics, Narayana Medical College, Nellore, Andhra Pradesh, India
R. Samba Siva Reddy Department of Pediatrics, Narayana Medical College, Nellore, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20174725

Keywords:

Bronchiolitis, Outcomes, Respiratory syncytial virus, Severity

Abstract

Background: Bronchiolitis is a predominant cause of respiratory insufficiency and hospitalization in infants during the first year of their life. Respiratory syncytial virus (RSV) has been the major causative virus; other viruses also cause bronchiolitis. Some are activated in winter while another virus in non-winter seasons. This seasonal trend affects the morbidity in infants. In the Indian context, data regarding seasonal influence on the severity and complications of acute bronchiolitis is less. Hence, this study was undertaken to assess the influence of season on morbidity on mortality in acute bronchiolitis.

Methods: Infants or children <2 years of age, with the first episode of acute bronchiolitis diagnosed clinically, were evaluated. Clinical, demographic, radiological and risk factors were recorded and correlated with seasons.

Results: The age of the infants was 4.0±2.9 months. Peak occurrence (87.7%) was within six months of age. 78/105 (74.3%) of bronchiolitis occurred during July to December. 22/105 (20.9%) were mild, 43/105 (43.9%) were moderate, and 40/105 (38.9%) were severe. The order of chest X-ray findings are consolidation <atelectasis <normal <pulmonary infiltrates <bilateral Hyperareation. Apnea was seen in 2.9%, Otitis media in 7.6% and seizures in 3.8% of infants. The season did not show statistically significant trend on the severity of bronchiolitis. There were no infant deaths due to bronchiolitis in the present study.

Conclusions: In the present study, the season did not show statistically significant trend on the severity of bronchiolitis. Studies with more extensive population are needed to reassess the seasonal effects on morbidity of acute bronchiolitis.

Metrics

Metrics Loading ...

References

Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Children. 1986;140(6):543-6. 2.

American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118(4):1774-93.

Holman RC, Shay DK, Curns AT, Lingappa JR, Anderson LJ. Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J. 2003;22(6):483-9.

Handforth J, Friedland J, Sharland M. Basic epidemiology and immunopathology of RSV in children. Pediatr Respir Rev. 2000;1(3):210-4.

Grimaldi M, Gouyon B, Michaut F, Huet F, Gouyon JB. Severe respiratory syncytial virus bronchiolitis: epidemiologic variations associated with the initiation of palivizumab in severely premature infants with bronchopulmonary dysplasia. Pediatr Infect Dis J. 2004;23(12):1081-5.

Korppi M, Piippo‐Savolainen E, Korhonen K, Remes S. Respiratory morbidity 20 years after RSV infection in infancy. Pediatr Pulmonol. 2004;38(2):155-60.

Hegele RG, Ahmad HY, Becker AB, Dimich-Ward H, Ferguson AC, Manfreda J, et al. The association between respiratory viruses and symptoms in 2-week-old infants at high risk for asthma and allergy. J Pediatr. 2001;138(6):831-7.

Mishra D, Singh H. Kuppuswamy’s socioeconomic status scale: a revision. Indian J Pediatr. 2003;70(3):273-4.

De Onis M, Onyango AW, Borghi E, Garza C, Yang H, Group WMGRS. Comparison of the World Health Organization (WHO) Child Growth Standards and the National Centre for Health Statistics/WHO international growth reference: implications for child health programmes. Public Health Nutr. 2006;9(7):942-7.

Zorc JJ, Hall CB. Bronchiolitis: recent evidence on diagnosis and management. Pediatr. 2010;125(2):342-9.

Petruzella FD, Gorelick MH. Current therapies in bronchiolitis. Pediatric Emergency Care. 2010;26(4):302-7.

Sala KA, Moore A, Desai S, Welch K, Bhandari S, Carroll CL. Factors associated with disease severity in children with bronchiolitis. J Asthma. 2015;52(3):268-72.

Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The burden of respiratory syncytial virus infection in young children. New Eng J Med. 2009;360(6):588-98.

Janahi I, Abdulkayoum A, Almeshwesh F, Alkuwari M, Al Hammadi A, Alameri M. Viral aetiology of bronchiolitis in hospitalised children in Qatar. BMC Infect Dis. 2017;17(1):139.

Heymann PW, Carper HT, Murphy DD, Platts-Mills TA, Patrie J, McLaughlin AP, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol. 2004;114(2):239-47.